Last reviewed · How we verify
MMP with 5-FU — Competitive Intelligence Brief
marketed
Topical chemotherapy combination
Dermatology/Oncology
Small molecule
Live · refreshed every 30 min
Target snapshot
MMP with 5-FU (MMP with 5-FU) — Clinica Dermatologica Arbache ltda. MMP with 5-FU is a topical combination therapy that uses matrix metalloproteinase modulation alongside 5-fluorouracil chemotherapy to treat skin lesions.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| MMP with 5-FU TARGET | MMP with 5-FU | Clinica Dermatologica Arbache ltda | marketed | Topical chemotherapy combination |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Topical chemotherapy combination class)
- Clinica Dermatologica Arbache ltda · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- MMP with 5-FU CI watch — RSS
- MMP with 5-FU CI watch — Atom
- MMP with 5-FU CI watch — JSON
- MMP with 5-FU alone — RSS
- Whole Topical chemotherapy combination class — RSS
Cite this brief
Drug Landscape (2026). MMP with 5-FU — Competitive Intelligence Brief. https://druglandscape.com/ci/mmp-with-5-fu. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab